Engineers Gate Manager’s Rhythm Pharmaceuticals RYTM Stock Holding History

Engineers Gate Manager’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,775	Closed	-$1.39M	–	2480
2025 Q3	$1.39M	Sell	13,775 -3,901	-22%	-$362K	0.02%	979
2025 Q2	$1.12M	Sell	17,676 -4,207	-19%	-$258K	0.01%	1058
2025 Q1	$1.16M	Buy	21,883 +2,700	+14%	+$150K	0.02%	980
2024 Q4	$1.07M	Buy	+19,183	New	+$1.06M	0.02%	969
2023 Q4	–	Sell	-13,071	Closed	-$300K	–	2212
2023 Q3	$300K	Buy	+13,071	New	+$293K	0.01%	1320
2022 Q1	–	Sell	-20,633	Closed	-$206K	–	2255
2021 Q4	$206K	Buy	+20,633	New	+$232K	0.01%	1640
2021 Q2	–	Sell	-32,710	Closed	-$696K	–	1965
2021 Q1	$696K	Buy	+32,710	New	+$949K	0.03%	793

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Engineers Gate Manager's RYTM Position: Q4 2025 in Review

Engineers Gate Manager sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2025, closing a stake of 13,775 shares — an estimated $1.39M sold.

Engineers Gate Manager first reported a position in RYTM in Q1 2021 and held it in 7 quarters. The position peaked at $1.39M in Q3 2025. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

Engineers Gate Manager reported no remaining Rhythm Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Engineers Gate Manager sold 13,775 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $1.39M.
Engineers Gate Manager first reported a position in Rhythm Pharmaceuticals in Q1 2021 and held it in 7 quarters.
Engineers Gate Manager's Rhythm Pharmaceuticals position peaked at $1.39M in Q3 2025.
279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.